These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17706624)

  • 21. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of treatment strategy on serum adiponectin, resistin and angiogenin concentrations in patients with stable multivessel coronary artery disease after one-year follow-up.
    Kręcki R; Krzemińska-Pakuła M; Peruga JZ; Szcześniak P; Lipiec P; Orszulak-Michalak D; Kasprzak JD
    Kardiol Pol; 2010 Dec; 68(12):1313-20. PubMed ID: 21174281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
    Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance of plasma high sensitive C-reactive protein in detecting three-vessel coronary artery disease: modification by apolipoprotein E genotype.
    Mennander A; Kuukasjärvi P; Laurikka J; Nikus K; Karhunen PJ; Tarkka M; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(8):714-9. PubMed ID: 18609102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.
    Walter MF; Jacob RF; Bjork RE; Jeffers B; Buch J; Mizuno Y; Mason RP;
    J Am Coll Cardiol; 2008 Mar; 51(12):1196-202. PubMed ID: 18355658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
    Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
    Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma resistin is increased in patients with unstable angina.
    Hu WL; Qiao SB; Hou Q; Yuan JS
    Chin Med J (Engl); 2007 May; 120(10):871-5. PubMed ID: 17543176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease.
    Kręcki R; Krzemińska-Pakuła M; Drożdż J; Szcześniak P; Peruga JZ; Lipiec P; Orszulak-Michalak D; Kasprzak JD
    Cardiol J; 2010; 17(6):599-606. PubMed ID: 21154263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistin level in coronary artery disease and heart failure: the central role of kidney function.
    Baldasseroni S; Mannucci E; Di Serio C; Orso F; Bartoli N; Mossello E; Foschini A; Monami M; Valoti P; Fumagalli S; Colombi C; Pellerito S; Gensini G; Marchionni N; Tarantini F
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):150-7. PubMed ID: 22240747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.
    Momiyama Y; Ohmori R; Uto-Kondo H; Tanaka N; Kato R; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2011; 18(2):108-14. PubMed ID: 21071880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.
    Ohmori R; Momiyama Y; Kato R; Taniguchi H; Ogura M; Ayaori M; Nakamura H; Ohsuzu F
    J Am Coll Cardiol; 2005 Jul; 46(2):379-80. PubMed ID: 16022972
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between increased serum resistin level and severity of coronary artery disease.
    Sinan UY; Canbolat IP; Baydar O; Oktay V; Imre G; Kocas C; Abaci O; Coskun U; Bostan C; Kilickesmez KO; Yildiz A; Kaya A; Gurmen T; Yigit Z
    Angiology; 2014 Mar; 65(3):239-42. PubMed ID: 24052521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.